|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.505 RUB | +10.15% |
|
-.--% | - |
| Market Cap | 1.36B 105B 1.18B 1.09B 1.01B 1.92B 129B 1.96B 13.1B 5.08B 63.32B 5.09B 4.98B 218B | P/E 2021 |
-2.42x | P/E 2022 | -6.53x |
|---|---|---|---|---|---|
| Enterprise Value | 2.09B 162B 1.83B 1.68B 1.57B 2.97B 199B 3.02B 20.21B 7.83B 97.7B 7.86B 7.69B 337B | EV / Sales 2021 |
5.43x | EV / Sales 2022 | 5.51x |
| Free-Float |
95.22% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 day | +10.15% |
| 5 years | 2.64 |  | 7 |
| 10 years | 2.64 | | 18.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 31/12/2013 | |
Alexey Shafranov
DFI | Director of Finance/CFO | 47 | - |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Gorelik
BRD | Director/Board Member | 47 | 31/12/2006 |
| Director/Board Member | 46 | 31/12/2012 | |
Dmitriy Genkin
CHM | Chairman | 57 | 31/12/2004 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.15% | -.--% | -.--% | -.--% | 25.27M | |
| +3.45% | +7.65% | +55.77% | +158.84% | 1,082B | |
| -1.16% | +7.42% | +69.09% | +58.92% | 633B | |
| -0.77% | +7.37% | +36.87% | +93.77% | 461B | |
| -0.37% | +1.85% | +31.30% | +24.86% | 339B | |
| -0.38% | +1.17% | +41.96% | +39.64% | 301B | |
| -0.16% | +1.49% | +32.40% | +44.75% | 292B | |
| -1.91% | +2.58% | -25.52% | -39.75% | 225B | |
| +3.55% | +6.05% | +26.04% | +68.52% | 202B | |
| +0.40% | +6.00% | +17.72% | +70.33% | 163B | |
| Average | +2.36% | +3.57% | +28.56% | +51.99% | 369.97B | |
| Weighted average by Cap. | +1.37% | +2.30% | +42.23% | +81.71% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 438M 34.01B 383M 352M 328M 622M 41.73B 632M 4.23B 1.64B 20.47B 1.65B 1.61B 70.53B | 380M 29.46B 332M 305M 284M 539M 36.14B 548M 3.67B 1.42B 17.73B 1.43B 1.39B 61.09B |
| Net income | -698M -54.12B -610M -560M -522M -990M -66.41B -1.01B -6.74B -2.61B -32.57B -2.62B -2.56B -112B | -207M -16.1B -181M -166M -155M -294M -19.75B -299M -2B -777M -9.69B -779M -762M -33.39B |
| Net Debt | 693M 53.76B 605M 556M 518M 983M 65.97B 1B 6.69B 2.59B 32.36B 2.6B 2.55B 111B | 736M 57.12B 643M 591M 551M 1.04B 70.09B 1.06B 7.11B 2.76B 34.38B 2.76B 2.7B 118B |
Employees
60
Sector
Pharmaceuticals
- Stock Market
- Stocks
- LIFE Stock
Select your edition
All financial news and data tailored to specific country editions
